Latest Changes

Title Description Major Minor Date
WARNING against colistin gradient tests The EUCAST Development Laboratory, together with several EUCAST Network Laboratories, have investigated the ability of current gradient tests (Etest and MTS) to accurately predict colistin MIC values. Both gradient tests underestimate the MIC-values, especially on and above the breakpoint of 2 mg/mL, leading to false susceptibility. 2016/07/07
EUCAST guidance: What to do when there are no breakpoints? What to do when there are no breakpoints? Sometimes there are no breakpoints for a certain species/agent combination. This document provides guidance from EUCAST on how to proceed. 2016/07/05
Evaluation of disks from 9 manufacturers updated 2016/07/01
VetCAST file from GC meeting in Amsterdam 2016 uploaded. "How VetCAST will define clinical breakpoints" - powerpoint presentation from ECCMID 2016 (presentation at the VetCAST general committee meeting) 2016/06/14
VetCAST presentations and minutes VetCAST met twice during ECCMID in Amsterdam. Presentations and minutes are now available from the VetCAST webpage. 2016/05/17
EUCAST releases three consultations (13 May - 24 June, 2016) 2016/05/13
The Brazilian NAC is now on the EUCAST website The Brazilian NAC was formed during 2016 and its website is now available from the EUCAST website. The NAC is working on translating EUCAST documents to Portuguese. 2016/05/08
Ceftobiprole Rationale Document published 2016/04/25
Statutes amended 2016-04-11 2016/04/17
EUCAST Network Laboratories Two documents pertaining to MIC testing of Candida and Aspergillus are mentioned in this document. The reference to them in the Network document has been updated. 2016/04/07
EUCAST Posters at ECCMID 2016 As usual, all EUCAST posters presented at ECCMID are summarised in one pdf-file and published on the website. These often report on ongoing work in EUCAST. 2016/04/06
Maps of uptake of EUCAST updated The maps showing the uptake of EUCAST recommendations have been updated. 2016/04/06
FAQ (Frequently Asked Questions) update 2016-03-29 2016/03/29
Reference MIC method for colistin 2016/03/22
Ukraine has formed a NAC Ukraine has formed a national AST committee (UCAST) and joined the EUCAST. More information is available on the page presenting all NACs. 2016/03/20
Canada has formed a NAC Canada has formed a NAC, CANCAST, to interact with EUCAST and other standards organisations in antimicrobial susceptibility testing. 2016/03/15
EUCAST Maps and Statistics updated The international implementation of EUCAST is shown as maps and statistics from external quality control programmes. Maps and stats were updated 2016-03-15. 2016/03/15
Compliance of manufacturers - updated version 10 March 2016 The document "Compliance of manufacturers of AST devices and materials" was updated 10 March 2016. 2016/03/10
Guidance note on the use of daptomycin in endocarditis caused by Enterococci 2016/03/04
QC tables updated from v 6.0 (January 2016) to v 6.1 (March 2016) Two changes were made between v 6.0 and 6.1: * Two zone diameter ranges updated in collaboration with CLSI: E. coli ATCC 25922 vs. meropenem 10 µg and P. aeruginosa ATCC 27853 vs. cefepime 30 µg. * Zone diameter target added for E. faecalis ATCC 51299 and the streptomycin 300 µg disk. 2016/03/01
EUCAST SOP 4.2 published The EUCAST SOP 4.2 (Committees and subcommittees) revised 2016/02/25
QC Table v 6.0 published An updated version of the QC tables (v 6.0) published with the following changes: - New agents added: Ceftolozane-tazobactam, dalbavancin, oritavancin and tedizolid. - New table with recommendations for β-lactam-β-lactamase inhibitor combination disks. - Several new zone diameter ranges for H. influenzae ATCC 49766. - H. influenzae NCTC 8468 excluded. 2016/01/10
Breakpoint tables v 6.0 pre-published The 2016 EUCAST Breakpoint tables (v 6.0) are made available. 2015/12/23
Two AFST methods documents updated The methods documents on MIC determination in yeasts and aspergillus have been updated. 2015/12/22
EUCAST documents available in Chinese 2015/11/23
AFST Clinical breakpoints v 8.0 New version of AFST Clinical breakpoints published 2015/11/16
Isavuconazole rationale document published Isavuconazole rationale document published 2015/11/16
QC AFST Table published QC AFST Table published 2015/11/16
Investigation into the quality of disks from 9 manufacturers. EUCAST has just concluded the second round of testing of disks from 9 manufacturers. Some were found to perform well whereas others exhibit grave potency/disk mass problems. Users of disks are advised to read the report and to heed the recommendations. Several manufacturers are advised to improve their process of manufacturing. 2015/10/23
Proposed changes to the intermediate category (consultation until 3 December, 2015). EUCAST is consulting on the proposed changes to the definition of the intermediate category. 2015/10/22
Consultation on "Intrinsic resistance and exceptional phenotypes" Consultation is open between October 8 and December 3, 2015. 2015/10/08
Nitroxoline breakpoints for consultation (deadline 28 November, 2015) 2015/10/07
EUCAST SOP 3 updated (2015-10-07) EUCAST SOP 3.0 Review and revision of EUCAST breakpoints has been updated to 3.1. 2015/10/07
AFST General Committee meeting 2015 - minutes The minutes from the AFST General Committee meeting 2015 in Copenhagen, and the chairperson´s report for 2014-15 are now available on the EUCAST website. 2015/08/12
Technical notes on candidae and aspergillus Published Technical Notes on voriconazole for Aspergillus and micafungin, anidulafungin and fluconazole for Candidae are now available. 2015/08/08
Listing EUCAST AFST Network Laboratories A list of the EUCAST network laboratories for developing and validating mathods for susceptibility testing of yeasts and moulds is now available. 2015/06/26
The EUCAST Subcommittee on Veterinary susceptibility testing The EUCAST VetCAST (The Veterinary Committee on Antimicrobial Susceptibility Testing) was formed 27 April, during ECCMID Copenhagen. 2015/05/15
Breakpoints for dalbavancin, oritavancin and tedizolid pulished. EMA has approved dalbavancin, oritavancin and tedizolid with breakpoints from EUCAST. 2015/04/19
Frequently Asked Questions updated 2015-03-23 - 2015/03/23
Files showing EUCAST MIC vs. Zone diameters were updated. The EUCAST graphs exhibiting the correlation between EUCAST MICs and the EUCAST disk diffusion zone diameters were updated. 2015/02/20
Revised methodology documents The EUCAST disk diffusion manual and slide show have been revised and updated. 2015/01/26
QC Tables v 5.0 published The EUCAST QC tables v 5.0 published. 2015/01/11
Breakpoint table 5.0 now available The finalised Breakpoint table v 5.0 is now available on the EUCAST website. Apart from some corrections of typos, there are some changes from the preliminary version published 2014-12-05. These are described on the page under this link.. 2015/01/01
Preliminary breakpoint table 5.0 for consultation The EUCAST Clinical Breakpoint Table v 5.0 (2015) is now available for wide consultation (from Dec 5 to Dec 19). Please send comments to Erika Matuschek. The final version of the table will be published on January 2, 2015. 2014/12/05
EUCAST SOP 9.0 EUCAST SOP 9.0 Procedure for establishing zone diameter breakpoints and quality control criteria for new antimicrobial agents The EUCAST SOP 9.0 describes the EUCAST procedure for establishing zone diameter breakpoints and quality control criteria for new antimicrobial agents. 2014/11/05
EUCAST Development and Network Laboratories The EUCAST methods for susceptibility testing of bacteria and fungi requires the lead of two dedicated laboratories and the help of many others. How this works is described in documents on Development and Network Laboratories. 2014/11/04
MIC-testing offered The EUCAST Development Laboratory offers to perform MIC testing on bacteria using broth microdilution quality controlled to the highest standard. 2014/11/04
Ceftaroline rational document published 2014/10/12
EUCAST QC Table v 4.0 published 5 Sept 2014 Information 2014-09-05: The EUCAST QC table v 4.0 (2014-09-05) - the most important changes and additions are: - MIC ranges for amoxicillin-clavulanic acid and ampicillin-sulbactam validated for testing with fixed inhibitor concentrations - MIC ranges for ceftobiprole - Zone diameter range for E. coli ATCC 25922 and pefloxacin 5 µg - New MIC range for S. aureus ATCC 29213 and telavancin with polysorbate-80 - Ranges for E. faecalis ATCC 29212 and ciprofloxacin, levofloxacin and norfloxacin - Tentative MIC ranges for H. influenzae ATCC 49766 2014/09/05
Updated AFST document 9.2 MIC determination in moulds - document 9.1 has been updated to v. 9.2. 2014/08/25